Business
OKYO CEO and CSO to Present and Leadership Team to Participate at Upcoming Scientific Conferences in May
Robert J. Dempsey, MBA, Chief Executive Officer, to present at EyeceleratorRaj Patil, PhD, Chief Scientific Officer, to present at ARVO LONDON and NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, today announced CEO presentation at Eyecelerator and leadership participation at the Association for Rese
About this update from Okyo Pharma Limited
[{"type":"image","alt":"OKYO Pharma LTD","displaySize":"","headline":null,"caption":"OKYO Pharma LTD","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":113,"url":"https://media.zenfs.com/en/globenewswire.com/a8bd0cda50c593b9f86805333401781f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/EzvqxeB.YqrUFZvL3LPLHQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE1OA--/https://media.zenfs.com/en/globenewswire.com/a8bd0cda50c593b9f86805333401781f","width":300,"height":113}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Robert J. Dempsey, MBA, Chief Executive Officer, to present at Eyecelerator","length":75,"tagName":"p"}]},{"val":[{"type":"text","content":"Raj Patil, PhD, Chief Scientific Officer, to present at ARVO","length":60,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":135,"olType":false},{"type":"text","content":"LONDON and NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, today announced CEO presentation at Eyecelerator and leadership participation at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Denver, Colorado.","length":444,"tagName":"p"},{"type":"text","content":"Upcoming Scientific Conferences:","length":32,"tagName":"p"},{"type":"text","content":"Eyecelerator: May 1, 2026Denver, Colorado","length":47,"tagName":"p"},{"type":"text","content":"Presentation Title: Addressing Unmet Needs in Corneal and Anterior Segment DiseasesPresentation Date/Time: Friday May 1, 2026, 2:10-2:15 PM MDTBreakout: Anterior Segment, Room 401Presenter: Robert J. Dempsey, Chief Executive Officer at OKYO PharmaModerators: Julie Schallhorn, MD, MS; Kuldev Singh, MD","length":310,"tagName":"p"},{"type":"text","content":"ARVO Annual Meeting: May 3-7, 2026Denver, Colorado","length":51,"tagName":"p"},{"type":"text","content":"Presentation Title: First-in-Human Study of Urcosimod to Treat Neuropathic Corneal Pain (NCP) Shows Clinically Meaningful Pain Reduction and Quality-of-Life Improvement in NCP Patients Presentation Date/Time: Tuesday May 5, 2026, 3:30 PM to 5:15 PM MDTPoster Presentation/Board: 3461/0044Session Title: Corneal Neuropathy and Ocular...